Faculty Articles
Identification of Hydroxysteroid (17β) Dehydrogenase Type 12 (HSD17B12) as a CD8+ T-cell-defined Human Tumor Antigen of Human Carcinomas
Publication Title
Cancer Immunology and Immunotherapy
ISSN
0340-7004
Publication Date
3-1-2011
Abstract
Hydroxysteroid (17β) dehydrogenase type 12 (HSD17B12) is a multifunctional isoenzyme functional in the conversion of estrone to estradiol (E2), and elongation of long-chain fatty acids, in particular the conversion of palmitic to archadonic (AA) acid, the precursor of sterols and the inflammatory mediator, prostaglandin E2. Its overexpression together with that of COX-2 in breast carcinoma is associated with a poor prognosis. We have identified the HSD17B12114–122 peptide (IYDKIKTGL) as a naturally presented HLA-A*0201 (HLA-A2)-restricted CD8+ T-cell-defined epitope. The HSD17B12114–122 peptide, however, is poorly immunogenic in its in vitro ability to induce peptide-specific CD8+ T cells. Acting as an ‘‘optimized peptide’’, a peptide (TYDKIKTGL), which is identical to the HSD17B12114–122 peptide except for threonine at residue 1, was required for inducing in vitro the expansion of CD8+ T-cell effectors cross-reactive against the HSD17B12114–122 peptide. In IFN-γ ELISPOT assays, these effector cells recognize HSD17B12114–122 peptide-pulsed target cells, as well as HLA-A2+ squamous cell carcinoma of the head and neck (SCCHN) and breast carcinoma cell lines overexpressing HSD17B12 and naturally presenting the epitope. Whereas growth inhibition of a breast carcinoma cell line induced by HSD17B12 knock-down was only reversed by AA, in a similar manner, the growth inhibition of the SCCHN PCI-13 cell line by HSD17B12 knockdown was reversed by E2 and AA. Our findings provide the basis for future studies aimed at developing cancer vaccines for targeting HSD17B12, which apparently can be functional in critical metabolic pathways involved in inflammation and cancer.
DOI
10.1007/s00262-011-1001-y
Volume
60
Disciplines
Medical Specialties | Medicine and Health Sciences | Osteopathic Medicine and Osteopathy
NSUWorks Citation
Visus, Carmen; Ito, Diasuke; Dhir, Rajiv; Szcezepanski, Miroslaw J.; Chang, Yoo Jung; Latimer, Jean J.; Grant, Stephen G.; and DeLeo, Albert B., "Identification of Hydroxysteroid (17β) Dehydrogenase Type 12 (HSD17B12) as a CD8+ T-cell-defined Human Tumor Antigen of Human Carcinomas" (2011). Faculty Articles. 960.
https://nsuworks.nova.edu/hpd_com_faculty_articles/960
